Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
23andMe CEO on Trading Debut, GSK Deal, Branson SPAC
Posted
June 17, 2021
Views
2,447
Likes
47
Comments
12
Engagement
June 17, 2021
2,447
47
12
2.41%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
6:04Now PlayingJun.17 -- 23andMe Inc. CEO Anne Wojcicki discusses the DNA-testing company's NASDAQ trading debut, a collaboration on drug development with GlaxoSmithKline Plc, and the choice to go public through a merger with VG Acquisition Corp., a special-purpose acquisition company founded by billionaire Richard Branson. She speaks with Bloomberg's Emily Chang on "Bloomberg Markets: The Close."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
